2014


To access this material please log in or register

Register Authorize
2014/№2

Effects of diuretics with different half-elimination times on changes in natriuresis and central hemodynamic parameters in patients with essential hypertension complicated with chronic heart failure

Arutyunov G. P.1, Dragunov D. O.1, Sokolova A. V.1, Morosanova E. I.2
1 - State Budgetary Educational Institution of Higher Professional Education, “N.I. Pirogov Russian National Research Medical University” of the RF Ministry of Health Care, Ostrovityanova 1, Moscow 117997
2 – Federal State Budgetary Educational Institution of Higher Professional Education “M. V. Lomonosov Moscow State University”, Leninskie Gory 1, GSP-1, Moscow 119991

Keywords: hyperpiesis, diuretics, natriuresis, CHF, central hemodynamics

DOI: 10.18087/rhj.2014.2.1951

Background. Patients with AH complicated with CHF are known to have increased potassium reabsorption which leads to changes in natriuresis and central hemodynamic parameters. Aim. To study natriuresis and effects of diuretics with different half-elimination times on natriuresis changes and central hemodynamic parameters in patients with AH and CHF. Materials and methods. The study included 56 patients who were divided into 2 groups. Each group consisted of 28 patients receiving torasemid SR or IR 10 mg / day. Salt sensitivity was determined by the M. H. Weinberger method. Salt consumption was recorded using study-specific diaries and by natriuresis. Natriuresis was measured spectrophotometrically using MET-Cl-PC and MET-creatinine-PC test systems both in spot urine and 8 samples collected according to Zimnitsky. Sodium and potassium levels were measured with an electrolyte analyzer EASYLYTE Na / K. Arteriography was performed by applanation tonometry using a TensioClinic arteriograph. Results. Three types of 24h sodium excretion pattern were observed: isohyponatriuretic, hyponatriuretic and isonatriuretic types. The treatment with torasemid SR and torasemid IR was associated with statistically non-significant difference between areas under curves (SIR=13603.8 and SSR=13 741.2; р>0.05); however the torasemid SR treatment resulted in smooth, “peakless” natriuresis. Comparison of central hemodynamic parameters at baseline and at 30 days showed that these parameters were significantly improved in the torasemid SR treatment group (р <0.05), which indicated a statistically significant difference between central hemodynamic parameters. Comparison of the same parameters in the torasemid IR treatment group also showed their improvement but the difference was not statistically significant (р>0.05). Conclusion. Administration of a loop diuretic with a short half-elimination time is associated with peaky diuresis, which results in damage of renal tubules by large amounts of sodium.
  1. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005 Apr;85 (2):679–715.
  2. Chirinos JA, Townsend R. Sodium, potassium, and target organ damage: a case for central hemodynamics. Hypertension. 2010;56 (4):578–580.
  3. Boutouyrie P, Bussy C, Lacolley P et al. Association between local pulse pressure, mean blood pressure and large artery remodeling. Circulation. 1999 Sep 28;100 (13):1387–93.
  4. Арутюнов Г. П. Патофизиологические процессы в почках у больных хронической сердечной недостаточностью. Журнал Сердечная Недостаточность. 2008;9 (5):234–250.
  5. Ruilope LM, van Veldhuisen DJ, Ritz E et al. Kidney dysfunction: a sensitive predictor of cardiovascular risk. Am J Hypertens. 2001;14 (6 Pt 2):213S-217S.
  6. Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol. 2001;38 (7):1782–1787.
  7. Magri P, Rao MA, Cangianiello S et al. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation. 1998;98 (25):2849–2854.
  8. Khawaja Z, Wilcox CS. Role of the kidneys in resistant hypertension. Int J Hypertens. 2011 Mar 14;2011:143471.
  9. Dussol B, Moussi-Frances J, Morange S et al. A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. J Clin Hypertens (Greenwich). 2012 Jan;14 (1):32–7.
  10. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27 (3 Pt 2):481–490.
  11. Арутюнов Г. П., Оганезова Л. Г., Драгунов Д. О. Патент № 2490636. Электронные бюллетени – изобретения и полезные модели. 2013; №23.
  12. Почки и гомеостаз в норме и при патологии: Пер. с англ. / Под ред. С. Клара. М.: Медицина, 1987, – 448с.
  13. Whelton PK, Appel LJ, Espeland MA et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279 (11):839–846.
  14. Cook NR, Cutler JA, Obarzanek E et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007 Apr 28;334 (7599):885–8.
  15. Roson MI, Cavallero S, Della Penna S et al. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int. 2006;70 (8):1439–1446.
  16. Elzinga LW, Rosen S, Bennett WM. Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. J Am Soc Nephrol. 1993;4 (2):214–221.
  17. F Gnanaraj J, von Haehling S, Anker SD et al. The relevance of congestionin the cardio-renal syndrome.Kidney Int. 2013 Mar;83 (3):384–91.
  18. van Paassen P, de Zeeuw D, de Jong PE, Navis G. Renin inhibition improves pressure natriuresis in essential hypertension. J Am Soc Nephrol. 2000 Oct;11 (10):1813–8.
  19. de la Sierra A, Lluch MM, Coca A et al. Assessment of salt sensitivity in essential hypertension by 24‑h ambulatory blood pressure monitoring. Am J Hypertens. 1995 Oct;8 (10 Pt 1):970–7.
  20. Castiglioni P, Parati G, Brambilla L et al. Detecting sodium-sensitivity in hypertensive patients: information from 24‑hour ambulatory blood pressure monitoring. Hypertension. 2011 Feb;57 (2):180–5.
  21. Wilson DK, Sica DA, Miller SB. Ambulatory blood pressure nondipping status in salt-sensitive and salt-resistant black adolescents. Am J Hypertens. 1999 Feb;12 (2 Pt 1):159–65.
  22. Ben-Dov IZ, Bursztyn M. Can salt sensitivity of blood pressure be assessed without changing salt diet? Hypertension. 2011 Feb;57 (2):156–7.
  23. Laurent S, Boutouyrie P, Asmar R et all. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37 (5):1236–1241.
  24. Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010 Oct;31 (19):2338–50.
  25. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM. Augmentation index is associated with cardiovascular risk. J Hypertens. 2002;20 (12):2407–2414.
  26. Park S, Park JB, Lakatta EG. Association of central hemodynamics with estimated 24‑h urinary sodium in patients with hypertension. J Hypertens. 2011 Aug;29 (8):1502–7.
  27. Резник Е. В., Гендлин Г. Е., Сторожаков Г. И. Дисфункция почек у больных с хронической сердечной недостаточностью: патогенез, диагностика, лечение. Журнал Сердечная Недостаточность. 2005;6 (6):245–251.
Arutyunov G. P., Dragunov D. O., Sokolova A. V. et al. Effects of diuretics with different half-elimination times on changes in natriuresis and central hemodynamic parameters in patients with essential hypertension complicated with chronic heart failure. Russian Heart Journal. 2014;76 (2):107–113

To access this material please log in or register

Register Authorize
Ru En